Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial
AbstractBackgroundThough SARS-CoV-2 an infection usually causes milder signs in kids and adolescents, younger individuals may nonetheless play a key half in SARS-CoV-2 transmission. An efficacious vaccine for kids and ...
Read more